<DOC>
	<DOCNO>NCT01548846</DOCNO>
	<brief_summary>This study whose main objective evaluate prospectively proportion patient severe xerostomia one year treatment tomotherapy head neck cancer .</brief_summary>
	<brief_title>Impact Tomotherapy Xerostomia Quality Life Patients With Cancer Upper Aero-digestive Tract</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<criteria>Patient ( e ) old ( e ) 18 year Patients squamous cell carcinoma head neck ( oral cavity , oropharynx , lymphadenopathy without gateway ) histologically prove . Patient target head neck radiotherapy Tomotherapy exclusive without concurrent chemotherapy ( contain platinum ) Indication head neck radiotherapy bilateral All TNM stage except metastatic Patient sign informed consent participation study Mastery French language History head neck radiotherapy Indication head neck radiotherapy unilateral Personal history malignant tumor uncontrolled past 5 year History oral sicca syndrome Surgical removal one salivary gland ( parotid , submandibular gland , sublingual gland ) Concomitant treatment amifostine Concomitant treatment cetuximab Primary tumor salivary gland Head neck hyperfractionated radiotherapy / accelerate Head neck radiotherapy hypofractionated Metastatic disease Patient deprive liberty , guardianship Any medical condition psychological associate could compromise patient 's ability participate study Refusal patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>tomotherapy</keyword>
	<keyword>xerostomy</keyword>
	<keyword>head neck squamous cell carcinoma</keyword>
</DOC>